You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site

Continue

Go back

Popup

ventolin_packshot

Ventolin

Ventolin (salbutamol sulphate) is indicated for the relief of bronchospasm in bronchial asthma of all types, Chronic Bronchitis & Emphysema.

About Ventolin
 

Symptom Relief

Fast onset of action within 5 minutes, peak bronchodilation within 10 minutes23

Legacy and Reliability

Over 50 years as a reliever for Asthma Patients12

Quality and Consistency

Ventolin Evohaler is subjected to rigorous quality control to ensure absolute precision4

ventolin-systemics-leave-behind

Open the door to effective relief

 

asthma-kid-image

Efficacy

A legacy of Asthma relief you can trust

SALBUTAMOL is considered the drug of choice as relief medication for symptoms of Bronchospasm due to its RAPID ONSET OF ACTION.

Learn more

Video player requires JavaScript enabled. You can download this video here: https://videos.gskstatic.com/pharma/GSKpro/Pakistan/MP4/Ventolin/ventolin-mdi-manufacturing-process-2021-video.mp4

Manufacturing Video

lungs

Safety

Safety Profile of Ventolin

Ventolin has an established safety profile and is generally well-tolerated; now also available in CRSF packaging.

Learn more

who_image

Guidelines

Guideline recommendations

Salbutamol is mentioned in WHO Model List of Essential Medicines 2019.

Find out more

Expert Video

See what the industry experts have to say about Ventolin

Video player requires JavaScript enabled. You can download this video here: https://videos.gskstatic.com/pharma/GSKpro/Pakistan/MP4/Ventolin/ventolin-pac-2021-hcp-video-review-of-ventolin-in-asthma.mp4

References:

  1. Sanders M. Prim Care Respir J 2007;16:71–81.
  2. Ventolin Evohaler Datasheet. Version Number: GDS24/IPI08. Date of Issue: 21st May 2013.
  3. Price AH, et al. Drugs 1989;38:77–122.
  4. GSK Data on File. Document number 2020N433633_00, March 2020.

Adverse Events must be reported. For products related to GSK Pakistan, please report adverse events via email at pk_pharmasafety@gsk.com or call us at +92 (21) 111 475 725 - Ext: 7&8.

Full prescribing information is available on request.
GlaxoSmithKline Pakistan Limited
35 - Dockyard Road, West Wharf, Karachi - 74000.
Ventolin and Evohaler are trademarks of GlaxoSmithKline group of companies. 
GlaxoSmithKline Pakistan Limited is a member of GlaxoSmithKline group of companies.
© 2021 GlaxoSmithKline Pakistan Limited.